Although great progress has been made in therapeutic interventions for coronary artery disease (CAD), it is still the deadliest disease in the world. Currently animals that are similar to human beings in their cardiovascular pathophysiology are being used to explore the pathogenesis and therapy of CAD. There have been a series of developments in creating CAD animal models using mice, rats, rabbits, dogs, and pigs, but unfortunately there is still no acceptable model for human CAD. The ideal CAD animal model should satisfy several conditions as follows. First of all, it should have a pathophysiological process for CAD that is similar to humans. Second, it should be useable for assessing drug efficacy. The last and most important condition is that the model can be used to duplicate clinical therapeutic skills. The limitations of current methods for making animal models have meant that these models not only do not duplicate the actual pathogenesis, but also cannot be used to simulate clinical therapy, and do not support scientific evaluation of drug efficacy. Therefore, the development of a fit-for-purpose animal model for CAD is imperative for future research. Such a development will lead to rapid progress and greater efficiency in CAD research. This paper summarizes the present situation in the field of CAD animal models, and puts forwards ideas for developing a novel animal model of myocardial infarction.
| INTRODUCTION
Although we have made great advances in the treatment of coronary artery disease (CAD), it remains an important public health challenge.
It is currently the disease with the highest mortality in the world.
With changes of lifestyle, more and more Chinese suffer from CAD, which constitutes a serious threat to the Chinese people and their society. Accordingly, more and more scientists are focusing their researches on this area.
Although great progress has been made in the treatment of CAD using drugs, thrombolysis, surgical interventions and gene therapy, there are still many challenges in CAD research that need to be resolved because the pathogenesis of this disease is not yet fully understood. At present, CAD is regarded as a disease involving multiple genes, with genetic and environmental factors interacting. Many experiments cannot be directly carried out in the human body for various reasons. Fortunately, in some animals the pathology of CAD is similar to that in humans, and therefore establishing an animal
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model for CAD would be an effective method for further exploring its pathogenesis and pathological processes and developing novel therapies.
| CURRENT RESE ARCH ON ANIMAL

MODELS OF CAD
CAD animal models have been tried with a variety of animals and methods, each with their advantages and disadvantages, but most animal models are different from humans in pathological process and corresponding symptoms. CAD is a myocardial dysfunction and/or organic lesion caused by coronary stenosis and insufficient blood supply. It is also known as ischemic cardiomyopathy. Hypertension, diabetes, obesity, cigarette smoking and "bad habits," leading to the formation of atherosclerosis (AS), are the main causes of the disease.
Myocardial ischemia is a characteristics of physiological and pathological changes caused by AS. The pathological changes in CAD include lipid infiltration, fatty streaks, atherosclerotic plaques and fibrous atherosclerotic plaque compound lesions. It is termed CAD when the coronary artery stenosis area caused by AS occupies 51% to 75% or more of the original area. 1 Myocardial ischemia (MI) occurs when the blood flow through the coronary artery is completely interrupted by plaque rupture, bleeding, or spasm, and ischemic necrosis occurs in the myocardium deprived of its blood supply. Therefore, in order to provide an ideal research medium for further exploring the pathogenesis, pathological process and effective treatment of CAD, and to make an objective evaluation of drugs or therapeutic methods, animal models with a pathological process similar to human CAD should be established to match the clinical situationas closely as possible.
Because of its small size, low cost, and fast reproduction, mouse has become the most commonly used animal model in the field of cardiovascular research. Both the apolipoprotein E knockout (ApoE KO) mice and the low density lipoprotein receptor knockout (LDL-R KO) mice are very popular due to their susceptibility to AS, They present with coronary AS, myocardial ischemia/infarction, and heart failure.
Although ApoE KO mice and LDL-R KO mice can form obvious AS under a high-fat diet, the plaques are mainly distributed in the aorta and its outflow tract, and less in the coronary artery. Therefore, the current CAD model in mice mainly depends on coronary artery ligation or isoproterenol injection. 2 This type of model and method cannot simulate the natural pathogenesis of human CAD and has obvious limitations since the underlying causes of CAD are not present.
Rats have the convenient characteristics of easy feeding, good survival rates and low maintenance cost, but there is no gallbladder in rats, so the absorption rate of exogenous cholesterol is low. In addition, because of the rat's characteristic of spontaneous anti-AS formation, it is difficult to induce AS lesions by high-fat diet alone.
Moreover, it has been found that there is an inter-adjustment state of plasma lipids and significant anorexia in the process of hyperlipidemia establishment in rats by high-fat diet feeding. 3 Therefore, most research has used a drugs and/or injury combined method to form AS lesions. 4 Although the morphology of the AS lesion and the rupture position of the plaque in rats are similar to those in humans, 5 this mode of modeling is still different from the natural pathogenesis of human CAD.
Rabbits are the most commonly used animal model of hyperlipidemia and AS. 6 They are sensitive to high-fat diet, and their absorption rate of exogenous cholesterol is up to 95%. They easily convert exogenous cholesterol into blood lipids, and have a low clearance rate of these lipids. However, rabbits are herbivores, with large differences in lipid metabolism from humans. The atherosclerotic plaques are formed mainly in the thoracic aorta, and coronary lesions mainly in small arteries in rabbits, while those in humans are formed mainly in large branches of the coronary arteries. The anatomy of the heart, coronary branches, coronary artery travel and coronary collateral circulation in rabbits are similar to those of humans. Arrhythmia due to coronary artery occlusion has a lower mortality rate in rabbits. 7 The cardiovascular system in canine models is well developed, and the nervous and humoral regulation systems are perfectly matched to the human system, while the volume is sufficient to get enough information. However, dogs have an extensive sidelimb circulation, large coronary artery variation, and some have wall arteries. The distribution of the left anterior descending branch is often broader than the left circumflex. Both of the branches can be easily ligated to make a myocardial ischemia model. Dogs are not good animal models of AS, however, because they cannot develop AS spontaneously, even under high-fat diet conditions, as is the case for rats and mice. 8 The physiology, anatomy, blood lipids, AS lesions, and lipoprotein metabolism mechanism in pigs are close to those in humans, 6 suggesting they would make a better model for mimicking human AS. The distribution, histological structure and pathogenesis of atherosclerotic plaques are similar to those of humans. The model of MI formed after the occlusion of the coronary artery branches is comparable to that of human MI. 9, 10 However, the pig's body shape, body signs and living habits are quite different from those of humans, and the model's production cycle is also very long. There are still many physiological discrepancies between pigs and primates.
The sheep myocardium shares many similarities with humans.
For example, the predominate myosin heavy chain isoform in sheep is the slow b-MHC, as in humans. 11 Various disease types can be developed in sheep, including, but not limited to, MI and gradual aortic constriction-induced heart failure. Most notably, sheep models are more expensive to produce and maintain in animal facilities than other small animal models. Compared with the intraperitoneal injection and intravenous injection of small animal models, another technical limitation is that adeno associated viruses are required to transduce sheep myocardial tissue.
| PRIMATES ARE POTENTIALLY IDEAL ANIMAL MODELS OF CAD
For practical purposes, the study of medicine must be based on scientific experiments in animals and the animal species must be TANG ET AL.
| 37 similar to humans in physiology and pathology. Theoretically, nonhuman primates are the most suitable for medical research because of their similarity to humans in genetic evolution, immunity, physiology, metabolism, and so on. Nonhuman primates are the best experimental models for the study of chronic diseases in humans because they have a long life cycle and similar biological characteristics to humans.
Animal models of human diseases established in non-human primates allow observation of the occurrence and development of the disease, as well as the complications. They also provide a reliable medium for efficacy testing of drugs and safety evaluation. 
M. fascicularis, also known as
| DISCUSSION
The disadvantages of current CAD models, summarized above, confirm that an ideal animal model needs to be established. The key problems to be solved are simulation of autologous coronary artery plaque formation and triggering of plaque rupture by the
researchers.
An ideal model should have these requirements: (1) it follows the natural pathophysiological process of CAD, (2) it can be used to observe the curative effect, mechanism and functional features of anti-myocardial ischemia drugs, thrombolysis and interventional therapy, (3) it can be used for long-term, continuous, systematic observation, (4) it should allow controlled, repeatable uncomplicated experiments, without side-effects, and the animals should be easy to operate, with a low mortality rate, (5) all animal experiments should be able to be approved by Animal Ethics Committees.
In summary, using modern science and technology such as molecular biology, the development of a fit-for-purpose CAD animal model is an important and imperative task for further exploration of the pathogenesis and pathological process of CAD, and of effective treatment methods and new drugs. Once a significant breakthrough is made, it will certainly be a powerful impetus to the development of CAD research.
